Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.53 - $1.89 $266 - $948
-502 Reduced 25.24%
1,487 $0
Q4 2023

Feb 13, 2024

BUY
$1.22 - $5.24 $1,532 - $6,581
1,256 Added 171.35%
1,989 $2,000
Q3 2023

Nov 14, 2023

SELL
$2.75 - $5.17 $1,020 - $1,918
-371 Reduced 33.61%
733 $2,000
Q2 2023

Aug 21, 2023

BUY
$4.09 - $8.29 $4,515 - $9,152
1,104 New
1,104 $4,000

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $92M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.